相似文献
1
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study.
Diabetes Res Clin Pract. 2021 May;175:108695. doi: 10.1016/j.diabres.2021.108695. Epub 2021 Feb 10.
2
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.
Diabetologia. 2020 Aug;63(8):1500-1515. doi: 10.1007/s00125-020-05180-x. Epub 2020 May 29.
3
Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study.
Eur J Endocrinol. 2021 Jul 5;185(2):299-311. doi: 10.1530/EJE-21-0068.
4
Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study.
Diabetes Obes Metab. 2021 Feb;23(2):391-403. doi: 10.1111/dom.14228. Epub 2020 Nov 6.
5
Preadmission predictors of severe COVID-19 in patients with diabetes mellitus.
J Diabetes Complications. 2021 Aug;35(8):107967. doi: 10.1016/j.jdiacomp.2021.107967. Epub 2021 May 28.
6
Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people with type 2 diabetes: A case-control study.
Diabetes Obes Metab. 2020 Oct;22(10):1946-1950. doi: 10.1111/dom.14097. Epub 2020 Jul 1.
7
Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium.
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):149-157. doi: 10.1016/j.dsx.2020.12.020. Epub 2020 Dec 14.
8
Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea.
Endocrinol Metab (Seoul). 2020 Dec;35(4):901-908. doi: 10.3803/EnM.2020.787. Epub 2020 Dec 10.
9
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
Endocrine. 2020 Dec;70(3):454-460. doi: 10.1007/s12020-020-02465-4. Epub 2020 Sep 1.
10
Clinical characteristics and outcomes of coronavirus disease 2019 infections among diabetics: A retrospective and multicenter study in China.
J Diabetes. 2020 Dec;12(12):919-928. doi: 10.1111/1753-0407.13098. Epub 2020 Oct 2.
引用本文的文献
1
COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia.
Vaccines (Basel). 2024 Jun 16;12(6):662. doi: 10.3390/vaccines12060662.
2
Coronavirus disease 19 and risk of hyperglycemia among Iraqi patients.
Egypt J Med Hum Genet. 2021;22(1):82. doi: 10.1186/s43042-021-00207-3. Epub 2021 Nov 26.
3
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review.
Diabetes Ther. 2024 Jan;15(1):33-60. doi: 10.1007/s13300-023-01465-7. Epub 2023 Sep 26.
4
Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study.
Nutr Diabetes. 2023 Jul 17;13(1):11. doi: 10.1038/s41387-023-00241-7.
5
The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course-A Narrative Review.
Front Clin Diabetes Healthc. 2022 Mar 10;3:812134. doi: 10.3389/fcdhc.2022.812134. eCollection 2022.
6
Pediatric endocrinopathies related to COVID-19: an update.
World J Pediatr. 2023 Sep;19(9):823-834. doi: 10.1007/s12519-022-00662-x. Epub 2022 Dec 8.
7
Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic - A Literature Review.
Curr Trop Med Rep. 2022;9(4):250-256. doi: 10.1007/s40475-022-00268-3. Epub 2022 Sep 26.
8
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.
Biomedicines. 2022 Aug 26;10(9):2089. doi: 10.3390/biomedicines10092089.
9
Influence of Nutritional Status and Physical Exercise on Immune Response in Metabolic Syndrome.
Nutrients. 2022 May 13;14(10):2054. doi: 10.3390/nu14102054.
10
COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study.
Curr Diab Rep. 2022 Feb;22(2):53-63. doi: 10.1007/s11892-022-01452-5.
本文引用的文献
1
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.
Diabetes Metab. 2021 Sep;47(5):101216. doi: 10.1016/j.diabet.2020.101216. Epub 2020 Dec 10.
2
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study.
Diabetes Metab. 2021 Mar;47(2):101202. doi: 10.1016/j.diabet.2020.10.001. Epub 2020 Oct 19.
3
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
Diabetes Res Clin Pract. 2020 Sep;167:108382. doi: 10.1016/j.diabres.2020.108382. Epub 2020 Aug 25.
4
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
5
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.
Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822. doi: 10.1016/S2213-8587(20)30272-2. Epub 2020 Aug 13.
6
COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them?
Diabetes Obes Metab. 2020 Dec;22(12):2507-2508. doi: 10.1111/dom.14170. Epub 2020 Aug 27.
7
Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series.
Lancet Diabetes Endocrinol. 2020 Aug;8(8):660-663. doi: 10.1016/S2213-8587(20)30221-7. Epub 2020 Jul 1.
8
New-Onset Diabetes in Covid-19.
N Engl J Med. 2020 Aug 20;383(8):789-790. doi: 10.1056/NEJMc2018688. Epub 2020 Jun 12.
9
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.
Diabetologia. 2020 Aug;63(8):1500-1515. doi: 10.1007/s00125-020-05180-x. Epub 2020 May 29.
10
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
Diabetes Obes Metab. 2020 Oct;22(10):1897-1906. doi: 10.1111/dom.14099. Epub 2020 Jun 30.
Zotero 插件